Stock Surge

Tandem Diabetes Care’s shares rose over 32% after the company released its fourth‑quarter earnings, which showed a 3% year‑over‑year revenue increase to $290 million. Worldwide insulin‑pump shipments reached 38,000 units, including 27,000 in the United States, reflecting the continued demand for its devices.